Watchlist Price Alert

ICON Public Limited (ICLR)

NASDAQ: ICLR · Real-Time Price · USD

146.97

1.31 (0.90%)

At close: Jun 16, 2025, 3:59 PM

146.34

-0.43%

After-hours: Jun 16, 2025, 06:16 PM EDT

0.90% (1D)

Bid	145.08
Market Cap	11.87B
Revenue (ttm)	8.19B
Net Income (ttm)	758.19M
EPS (ttm)	9.18
PE Ratio (ttm)	16.01
Forward PE	10.27
Analyst	Buy

Ask	150
Volume	835,468
Avg. Volume (20D)	1,491,957
Open	145.89
Previous Close	145.66
Day's Range	143.19 - 147.26
52-Week Range	125.10 - 347.72
Beta	1.16

About ICLR

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ICLR

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ICLR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 month ago

-4.11%

Icon shares are trading lower after the company re... Unlock content with Pro Subscription

1 month ago

+1.43%

Icon shares are trading lower after the company reported worse-than-expected Q1 sales results.

News

2 weeks ago · businesswire.com

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm.

2 weeks ago · zacks.com

Here's Why You Should Retain ICLR Stock in Your Portfolio Now

Investors remain optimistic about ICON, driven by its commitment to enhance clinical delivery by integrating AI and impressive strategic pacts.

2 weeks ago · businesswire.com

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the William Blair 45th Annual Growth Stock Conference.

4 weeks ago · businesswire.com

ICON releases its ICON Cares 2024 Report

DUBLIN--(BUSINESS WIRE)--ICON releases its ICON Cares 2024 Report.

1 month ago · businesswire.com

Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma p...

1 month ago · seekingalpha.com

ICON Public Limited Company (ICLR) Q1 2025 Earnings Call Transcript

ICON Public Limited Company (NASDAQ:ICLR ) Q1 2025 Earnings Call Transcript May 1, 2025 8:00 AM ET Company Participants Kate Haven - Vice President, Investor Relations Steve Cutler - Chief Executive O...

1 month ago · zacks.com

ICON's Q1 Earnings Surpass Estimates, Revenues Lag, Stock Down

ICLR posts mixed results in the first quarter of 2025 due to ongoing clinical development and market volatility.

1 month ago · zacks.com

Icon PLC (ICLR) Beats Q1 Earnings Estimates

Icon PLC (ICLR) came out with quarterly earnings of $3.19 per share, beating the Zacks Consensus Estimate of $3.08 per share. This compares to earnings of $3.47 per share a year ago.